Global Value, Access and Commercialization Director - Regenerative Medicines

Company Overview Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner. Position Overview Global Value and Access Director – Regenerative Medicine. This individual will lead execution of market access, pricing, and reimbursement plans across global markets outside the US. Responsibilities Lead OUS Market Access Strategy and plan and an overall commercialization. Execution lead development and execution of OUS market access, pricing, and reimbursement strategies across priority OUS markets, aligned with centrally defined global strategy. Translate overall global strategic objectives into actionable OUS launch plan including the market access workstreams, milestones, and deliverables aligned with global timelines. Own and drive day‑to‑day execution of OUS market access priorities across assets, ensuring alignment to central strategy, timelines, and long‑range plans. Drive OUS launch readiness activities related to access pathways, reimbursement planning, and pricing implementation. Identify market‑specific access risks, reimbursement barriers, policy constraints, and operational dependencies that may impact OUS launch readiness or uptake. Contribute to long‑range planning for international access, including launch sequencing assumptions, affordability considerations, and stakeholder engagement priorities. Provide structured ex‑US market insights to inform global access strategy, evidence planning, and value narrative development. HTA, Pricing, and Reimbursement: Lead HTA planning and execution across priority markets, including EU JCA and relevant country‑level reimbursement pathways. Develop country‑level pricing and reimbursement recommendations aligned with centrally defined pricing guardrails. Support pricing and reimbursement negotiations in partnership with regional stakeholders, affiliates, and external partners as applicable. Monitor international pricing, reimbursement, and policy developments—including reference pricing and analogous cross‑market risks—and recommend mitigation strategies. Represent ex‑US access perspectives in cross‑functional planning and governance forums, escalating key trade‑offs and recommendations as appropriate. Accountable for OUS access outcomes, including HTA success, reimbursement readiness, pricing alignment, and time to market access. Qualifications Bachelor’s degree required; advanced degree preferred (e.g., MBA, MPH, PharmD, PhD, MS, or equivalent). 10+ years of progressive business experience in the healthcare, pharma or biotech industry, inclusive of global market access, pricing & reimbursement, value strategy, HEOR interface, or global commercial strategy. Experience in cell, gene, and regenerative medicines a plus. Experience with EU markets and country‑level HTAs, pricing and reimbursement; JCA experience preferred. Strong understanding of payer, reimbursement, HTA, and access dynamics in OUS settings. Ability to synthesize clinical, economic, operational, and policy information into clear strategic recommendations. Excellent communication, executive presence, and stakeholder management skills. Experience in rare disease, specialty therapeutics, biologics, cell therapy, gene therapy, tissue‑based therapies, or other advanced modalities highly preferred. Experience partnering with regional teams, affiliates, distributors, or external commercialization partners. Comfort operating in a dynamic, ambiguous environment where access strategy must be developed in parallel with evolving clinical and regulatory plans. Must be comfortable spending 30% of time traveling; some overnight travel required. Compensation & Benefits The base salary range for this role is $196,400.00 - $245,500.00. In addition to base salary, compensation includes merit‑based salary increases, short incentive plan participation, eligibility for a 401(k) plan, medical, dental, vision, life and disability insurances, and leaves in line with the work state. Robust time‑off policy includes flexible paid time off, 11 paid holidays, additional time off for a shut‑down period during the last week of December, and 80 hours of paid sick time upon hire and each year thereafter. Equal Employment Opportunity Sumitomo Pharma America (SMPA) is an Equal Employment Opportunity (EEO) employer. Qualified applicants will receive consideration for employment without regard to race, color, creed, religion, national origin, age, ancestry, nationality, marital, domestic partnership or civil union status, sex, gender, sexual orientation, disability, veteran or military status or liability for military status, domestic violence victim status, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law. Accessibility Sumitomo Pharma America (SMPA) endeavors to make its application process accessible to all. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process, please contact SMPA at reasonableaccomodations@us.sumitomo-pharma.com. This contact information is for accommodation requests only and cannot be used to inquire about the status of applications. #J-18808-Ljbffr